Celldex Therapeutics, Inc. Share Price Nasdaq
Equities
US15117B1035
Biotechnology & Medical Research
Sales 2024 * | 2.71M 214M | Sales 2025 * | 2.66M 210M | Capitalization | 2.65B 209B |
---|---|---|---|---|---|
Net income 2024 * | -153M -12.07B | Net income 2025 * | -196M -15.47B | EV / Sales 2024 * | 975 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 996 x |
P/E ratio 2024 * |
-17.4
x | P/E ratio 2025 * |
-14
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 31/12/82 |
Anthony Marucci
FOU | Founder | 62 | 31/12/82 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 31/03/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 29/02/08 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 15/06/22 |
Harry Penner
BRD | Director/Board Member | 78 | 31/12/96 |
1st Jan change | Capi. | |
---|---|---|
+33.14% | 49.46B | |
+1.99% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+12.10% | 26.61B | |
-23.09% | 18.64B | |
+8.45% | 13.16B | |
+30.32% | 12.55B | |
+24.17% | 12.1B |